Status:
RECRUITING
Prospective Cohort Study of Neurogenetic Diseases
Lead Sponsor:
University Hospital, Bordeaux
Conditions:
Genetic Disease
Nervous System Diseases
Eligibility:
All Genders
6+ years
Phase:
NA
Brief Summary
Neurogenetic diseases (NGD) represent rare and hereditary forms of neurological diseases. The goal of CNGD is to create a one-window approach for NGDs, to facilitate and accelerate participation in re...
Detailed Description
Neurogenetic diseases (NGDs) represent rare inherited forms of neurological diseases. They constitute a constellation of different diseases, affecting neurodevelopment (syndromic or non-syndromic inte...
Eligibility Criteria
Inclusion
- Patient-specific inclusion criteria
- Age ≥ 6 years
- Patient with a molecularly identified NGD
- o Specific inclusion criteria for controls
- For the 10 controls with lumbar puncture (LP): person who performed an LP for medical reasons and who consented to participate in the collection of biological samples
- Age ≥ 18 years
- Person matched in age (+/- 5 years) and sex to adult patient with NGD at the time of collection
Exclusion
- Participation in an interventional clinical trial that may interfere with our study
- Refusal of blood collection
- Pregnant and breastfeeding women
- Only for patients performing LP: Contraindication to LP
- Specific non-inclusion criteria for controls: Criterion of a neurodegenerative or inflammatory pathology of the central nervous system
Key Trial Info
Start Date :
July 18 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2030
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT06048523
Start Date
July 18 2024
End Date
July 1 2030
Last Update
February 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu de Bordeaux
Bordeaux, France